Natus Medical Story

Natus Medical Incorporated -- USA Stock  

USD 28.55  0.4  1.42%

Macroaxis does not monitor all media channels or aggregates social signals for Natus Medical. But even though we do not provide professional-grade financial sentiment analysis on Natus Medical Incorp, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Natus Medical. Check also Natus Medical Hype Analysis, Natus Medical Correlation and Natus Medical Performance
Acquisition by Doris Engibous of 4100 shares of Natus Medical subject to Rule 16b-3
Filed transaction by Natus Medical Inc director. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Natus Medical Incorporated insider trading alert for grant of common stock $0.001 par value per share by Doris Engibous, the corporate stakeholder, on June 23, 2017. This event was filed by Natus Medical Inc with SEC on 2017-06-23. Statement of changes in beneficial ownership - SEC Form 4

Cash Floor Correlation

Click cells to compare fundamentals   View All Correlations

Story Momentum

This media report from MacroaxisInsider distributed on June 23, 2017 was a factor to the next trading day price appreciation.The overall trading delta against the next closing price was 0.71% . The trading delta at closing time when the story was published against the current closing price is 20.03% .

Similar stores for Natus Medical

a day ago at 
Sentinel Trust Company Lba Has Upped Its Intel Position Natus Medical ...
Natus Medical Incorporated provides newborn care and neurology healthcare services and products worldwide. The company has market cap of 862.62 million. It offers services and products used for the screening, diagnosis, detection, treatment ...
over a month ago at 
Sientra Holder Cannell Capital Lifted Position by 3.46 Million Natus ...
J. Carlo Cannell increased its stake in Sientra Inc by 33.69 percent based on its latest 2017Q2 regulatory filing with the SEC.
over two months ago at 
The Natus Medical Inc. Upgrade to Hold at The Zacks Investment Research
BangaloreWeeklyFull coverage
over three months ago at 
Natus Medical CEO James Hawkins on Q2 2017 Results - Earnings Call ...
seekingalpha News
Seeking Alpha - Jul 26, 2017 Earlier today, Natus Medical released financial results for the second quarter 2017. If you have not received the news release or if you would like to be added to the company distribution list, please e-mail your request to Natus Medical Announces Second Quarter 2017 Financial Results - GlobeNewswire

Did you try this?

Run Portfolio Reporting Now

Portfolio Reporting

Create custom reports across your portfolios and generate quick suggestion pitch
Hide  View All  NextLaunch Portfolio Reporting

Gross Profit

Gross Profit Comparative Analysis
  Gross Profit 
      Natus Medical Comparables 
Natus Medical is currently under evaluation in gross profit category among related companies. Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.